Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis

Purpose: Developing an MRI-based radiomics model to effectively and accurately predict the predominant histopathologic growth patterns (HGPs) of colorectal liver metastases (CRLMs). Materials and Methods: In this study, 182 resected and histopathological proven CRLMs of chemotherapy-naive patients from two institutions, including 123 replacement CRLMs and 59 desmoplastic CRLMs, were retrospectively analyzed. Radiomics analysis was performed on two regions of interest (ROI), the tumor zone and the tumor-liver interface (TLI) zone. Decision tree (DT) algorithm was used for radiomics modeling on each MR sequence, and fused radiomics model was constructed by combining the radiomics signature of each sequence. The clinical and combination models were developed through multivariate logistic regression method. The performance of the developed models was assessed by receiver operating characteristic (ROC) curves with indicators of area under curve (AUC), accuracy, sensitivity, and specificity. A nomogram was constructed to evaluate the discrimination, calibration, and usefulness. Results: The fused radiomicstumor and radiomicsTLI models showed better performance than any single sequence and clinical model. In addition, the radiomicsTLI model exhibited better performance than radiomicstumor model (AUC of 0.912 vs. 0.879) in internal validation cohort. The combination model showed good discrimination, and the AUC of nomogram was 0.971, 0.909, and 0.905 in the training, internal validation, and external validation cohorts, respectively. Conclusion: MRI-based radiomics method has high potential in predicting the predominant HGPs of CRLM. Preoperative non-invasive identification of predominant HGPs could further explore the ability of HGPs as a potential biomarker for clinical treatment strategy, reflecting different biological pathways.

[1]  D. Gu,et al.  Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method , 2019, Annals of Surgical Oncology.

[2]  D. Dong,et al.  Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study , 2019, Clinical and translational gastroenterology.

[3]  Yanhui Ding,et al.  Stability of MRI Radiomics Features of Hippocampus: An Integrated Analysis of Test-Retest and Inter-Observer Variability , 2019, IEEE Access.

[4]  Antoine Vacavant,et al.  Automatic segmentation methods for liver and hepatic vessels from CT and MRI volumes, applied to the Couinaud scheme , 2019, Comput. Biol. Medicine.

[5]  M. Ravanelli,et al.  Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy , 2019, La radiologia medica.

[6]  H. Ulmer,et al.  Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score , 2019, PloS one.

[7]  Luc Y Dirix,et al.  Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases , 2019, Angiogenesis.

[8]  R. Labianca,et al.  Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group. , 2018, European journal of cancer.

[9]  B. Bozóky,et al.  Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review , 2018, BMJ open gastroenterology.

[10]  Hyunjin Park,et al.  Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer , 2018, Clinical Cancer Research.

[11]  P. Vermeulen,et al.  Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti‐angiogenic therapies , 2018, The journal of pathology. Clinical research.

[12]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  Lawrence H. Schwartz,et al.  Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab , 2017, Neuro-oncology.

[14]  Yves Sucaet,et al.  International consensus guidelines for scoring the histopathological growth patterns of liver metastasis , 2017, British Journal of Cancer.

[15]  Sohil H. Patel,et al.  T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project , 2017, Clinical Cancer Research.

[16]  John Quackenbush,et al.  Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.

[17]  N. Paragios,et al.  Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  E. Wallen,et al.  Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study , 2017, Scientific Reports.

[19]  M. Cheetham,et al.  The multimorbidity interaction severity index (MISI) , 2017, Medicine.

[20]  G. G. Van den Eynden,et al.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases , 2016, Nature Medicine.

[21]  M. Götz,et al.  Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response , 2016, Clinical Cancer Research.

[22]  Yanqi Huang,et al.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. , 2016, Radiology.

[23]  P. Soler-Palacín,et al.  Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients , 2016, Medicine.

[24]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[25]  A. Shinagare,et al.  Update on the role of imaging in management of metastatic colorectal cancer. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[26]  P. Lambin,et al.  Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability , 2013, Acta oncologica.

[27]  G. Jayson,et al.  Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors? , 2012, Clinical Cancer Research.

[28]  I. Christensen,et al.  Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases , 2012, Journal of oncology.

[29]  G. G. Van den Eynden,et al.  The histological growth pattern of colorectal cancer liver metastases has prognostic value , 2012, Clinical & Experimental Metastasis.

[30]  A. Jackson,et al.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.

[31]  Brandon Whitcher,et al.  DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 , 2011, British Journal of Cancer.

[32]  Feiping Nie,et al.  Efficient and Robust Feature Selection via Joint ℓ2, 1-Norms Minimization , 2010, NIPS.

[33]  E. van Marck,et al.  Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia , 2001, The Journal of pathology.

[34]  K. Hatakeyama,et al.  Computed tomographic features of colorectal carcinoma liver metastases predict posthepatectomy patient survival , 2001, Diseases of the colon and rectum.

[35]  R. Semelka,et al.  Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. , 2000, Radiology.